Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

566 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Optimum selection criteria for secondary cytoreductive surgery in patients with recurrent epithelial ovarian cancer: A multicenter study from the Gynecologic Oncology Research Investigators coLLaborAtion group (GORILLA-3001).
Son JH, Kong TW, Park SJ, Lee EJ, Kim HS, Kim NK, Kim Y, Hwang WY, Suh DH, Kim TH, Yang EJ, Shim SH, Chang SJ. Son JH, et al. Among authors: shim sh. J Surg Oncol. 2023 Sep;128(4):645-652. doi: 10.1002/jso.27303. Epub 2023 May 1. J Surg Oncol. 2023. PMID: 37126413
Fertility-sparing hormonal treatment in patients with stage I endometrial cancer of grade 2 without myometrial invasion and grade 1-2 with superficial myometrial invasion: Gynecologic Oncology Research Investigators coLLaborAtion study (GORILLA-2001).
Lee AJ, Yang EJ, Kim NK, Kim Y, Suh DH, Kim J, Son JH, Kong TW, Chang SJ, Hwang DW, Park SJ, Kim HS, Yoo JG, Lee SJ, Lee YY, Shim SH. Lee AJ, et al. Among authors: shim sh. Gynecol Oncol. 2023 Jul;174:106-113. doi: 10.1016/j.ygyno.2023.04.027. Epub 2023 May 10. Gynecol Oncol. 2023. PMID: 37172410
Is minimally invasive radical surgery safe for patients with cervical cancer ≤2 cm in size? (MISAFE): Gynecologic Oncology Research Investigators coLLborAtion study (GORILLA-1003).
Kong TW, Kim J, Son JH, Lee AJ, Yang EJ, Shim SH, Kim NK, Kim Y, Suh DH, Hwang DW, Park SJ, Kim HS, Lee YY, Yoo JG, Lee SJ, Chang SJ. Kong TW, et al. Among authors: shim sh. Gynecol Oncol. 2023 Sep;176:122-129. doi: 10.1016/j.ygyno.2023.07.009. Epub 2023 Jul 27. Gynecol Oncol. 2023. PMID: 37515926
Risk factors for the failure of first-line PARP inhibitor maintenance therapy in patients with advanced ovarian cancer: Gynecologic Oncology Research Investigators Collaboration Study (GORILLA-3004).
Kim NK, Kim Y, Kim HS, Park SJ, Hwang DW, Lee SJ, Yoo JG, Chang SJ, Son JH, Kong TW, Kim J, Shim SH, Lee AJ, Suh DH, Lee YY. Kim NK, et al. Among authors: shim sh. Cancer Med. 2023 Oct;12(19):19449-19459. doi: 10.1002/cam4.6546. Epub 2023 Sep 28. Cancer Med. 2023. PMID: 37768030 Free PMC article.
Lymphadenectomy in clinically early epithelial ovarian cancer and survival analysis (LILAC): a Gynecologic Oncology Research Investigators Collaboration (GORILLA-3002) retrospective study.
Yang EJ, Lee AJ, Hwang WY, Chang SJ, Kim HS, Kim NK, Kim Y, Kong TW, Lee EJ, Park SJ, Son JH, Suh DH, Son DH, Shim SH. Yang EJ, et al. Among authors: shim sh. J Gynecol Oncol. 2024 Jul;35(4):e75. doi: 10.3802/jgo.2024.35.e75. Epub 2024 Mar 12. J Gynecol Oncol. 2024. PMID: 38497109 Free PMC article.
Comparison of Outcomes in Bowel Resections by Gynecologic Oncologists Versus General Surgeons During Maximal Cytoreductive Surgery for Advanced Ovarian Cancer: Gynecologic Oncology Research Investigators Collaboration Study (GORILLA-3006).
Kim MS, Lee AJ, Shim SH, Jang EB, Kim NK, Kim MK, Suh DH, Kim J, Son JH, Kong TW, Chang SJ, Hwang DW, Park SJ, Kim HS, Yoo JG, Lee SJ, Lee YY. Kim MS, et al. Among authors: shim sh. Ann Surg Oncol. 2024 Sep;31(9):6040-6047. doi: 10.1245/s10434-024-15643-9. Epub 2024 Jul 3. Ann Surg Oncol. 2024. PMID: 38961041
Safety and efficacy study of laparoscopic or robotic radical surgery using an endoscopic stapler for inhibiting tumour spillage of cervical malignant neoplasms evaluating survival (SOLUTION): a multi-centre, open-label, single-arm, phase II trial protocol.
Park SJ, Kong TW, Kim T, Lee M, Choi CH, Shim SH, Yim GW, Lee S, Lee EJ, Lim MC, Chang SJ, Lee SJ, Lee SH, Song T, Lee YY, Kim HS, Nam EJ. Park SJ, et al. Among authors: shim sh. BMC Cancer. 2022 Mar 26;22(1):331. doi: 10.1186/s12885-022-09429-z. BMC Cancer. 2022. PMID: 35346103 Free PMC article.
Gastrointestinal/genitourinary perforation and fistula formation with or without bevacizumab in patients with previously irradiated recurrent cervical cancer: a Korean multicenter retrospective study of the Gynecologic Oncology Research Investigators Collaboration (GORILLA) group (GORILLA-1001).
Hwang WY, Chang SJ, Kim HS, Kim NK, Kim TH, Kim Y, Kong TW, Lee EJ, Park SJ, Shim SH, Son JH, Suh DH, Yang EJ. Hwang WY, et al. Among authors: shim sh. BMC Cancer. 2022 Jun 2;22(1):603. doi: 10.1186/s12885-022-09695-x. BMC Cancer. 2022. PMID: 35655188 Free PMC article.
566 results